Clinical Trial of GeoVax’s AIDS Vaccine Moves Forward

As President Obama prepares to release his U.S. AIDS strategy, at least one pharmaceutical company is readying a crucial clinical trial of its vaccine against HIV/AIDS.

Read more »

Ovatech Leaves the Hormones Out of Birth Control

Ovatech of Auburndale, Mass., is developing the world’s first non-hormonal, female-controlled contraception device.

Read more »

Potential Breakthrough in Search for AIDS Vaccine

Scientists at the Scripps Research Institute have isolated two antibodies that can prevent patients with HIV from developing severe AIDS.

Read more »

Special Report: Fighting the U.S. AIDS Epidemic

An estimated 1.2 million people in the U.S. have the HIV virus. OneMedPlace speaks with AIDS advocate Michael Manganiello about the scope of the epidemic, the possibility of a vaccine, and what needs to happen to make a national AIDS strategy a reality.

Read more »

GlaxoSmithKline, Pfizer Team Up Against HIV

The collaboration of two pharmaceutical giants may mark the beginning of an industry shift. Pfizer and GlaxoSmithKline are combining their HIV drug businesses into a single, jointly owned company that will account for almost 20 percent of the market.

Read more »